This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the medication Bydureon BCISE, a diabetes treatment, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,850.15 and a period of performance through December 2024. The award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is one of many that demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.
Generated 3/23/25, 12:50 AM